Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation

Am J Med Genet A. 2017 May;173(5):1342-1347. doi: 10.1002/ajmg.a.38110. Epub 2017 Mar 23.

Abstract

Features of Costello Syndrome, a systemic disorder caused by germline mutations in the proto-oncogene HRAS from the RAS/MAPK pathway, include failure-to-thrive, short stature, coarse facial features, cardiac defects including hypertrophic cardiomyopathy, intellectual disability, and predisposition to neoplasia. Two unrelated boys with Costello syndrome and an HRAS mutation (p.Gly13Cys) are presented with their ophthalmologic findings. Both had early symptoms of nystagmus, photophobia, and vision abnormalities. Fundus examination findings of retinal dystrophy were present at age 3 years. Both boys have abnormal electroretinograms with reduced or undetectable rod responses along with reduced cone responses consistent with rod-cone dystrophy. Our observations suggest that early ophthalmic examination and re-evaluations are indicated in children with Costello syndrome.

Keywords: Costello syndrome; HRAS mutation; Retinal Dystrophy.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics*
  • Abnormalities, Multiple / physiopathology
  • Adult
  • Child
  • Costello Syndrome / complications
  • Costello Syndrome / genetics*
  • Costello Syndrome / physiopathology
  • Genotype
  • Germ-Line Mutation
  • Humans
  • Male
  • Phenotype
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Retinal Dystrophies / complications
  • Retinal Dystrophies / genetics*
  • Retinal Dystrophies / physiopathology

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)